Androgen-receptor gene structure and function in prostate cancer

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Androgen-receptor (AR) gene mutations are observed in prostate cancer, both before and after treatment.
• These mutations can retain AR activity, even with altered ligand specificity.
• Mutant AR activation by non-androgen ligands may promote cancer cell survival.

Purpose of the Study:

• To investigate the role and timing of AR gene mutations in prostate cancer development and progression.
• To understand how AR mutations influence ligand specificity and cellular response to therapy.
• To explore alternative mechanisms of AR dysregulation in tumors lacking AR mutations.

Main Methods:

• Analysis of AR gene mutations in clinical prostate cancer samples.
• Assessment of AR activity and ligand specificity in mutated and wild-type forms.
• Investigation of AR gene amplification as a mechanism for altered AR function.

Main Results:

• AR mutations can be present prior to therapy and are associated with hormone-refractory disease.
• Some AR mutations broaden ligand specificity, allowing activation by estrogens and weak androgens.
• AR gene amplification is another mechanism affecting AR activity in tumors without mutations.
• Normal AR gene function, modulated by allelic variants, plays a predominant role in early-stage prostate cancer.

Conclusions:

• AR mutations occurring before treatment may indicate a more aggressive prostate cancer phenotype.
• AR dysregulation, through mutation or amplification, contributes to prostate cancer progression.
• The normal AR gene and its variants are crucial in the early development of prostate cancer.